Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-044329
Filing Date
2024-11-08
Accepted
2024-11-08 17:00:30
Documents
49
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 985922
2 ex31-1.htm EX-31.1 13045
3 ex31-2.htm EX-31.2 12819
4 ex32-1.htm EX-32.1 6296
5 ex32-2.htm EX-32.2 6842
  Complete submission text file 0001493152-24-044329.txt   4789377

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE bfrg-20240930.xsd EX-101.SCH 35821
7 XBRL CALCULATION FILE bfrg-20240930_cal.xml EX-101.CAL 33751
8 XBRL DEFINITION FILE bfrg-20240930_def.xml EX-101.DEF 167955
9 XBRL LABEL FILE bfrg-20240930_lab.xml EX-101.LAB 364215
10 XBRL PRESENTATION FILE bfrg-20240930_pre.xml EX-101.PRE 265856
51 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 663157
Mailing Address 325 ELLINGTON BLVD. UNIT 317 GAITHERSBURG MD 20878
Business Address 325 ELLINGTON BLVD. UNIT 317 GAITHERSBURG MD 20878 3013672055
BullFrog AI Holdings, Inc. (Filer) CIK: 0001829247 (see all company filings)

EIN.: 844786155 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41600 | Film No.: 241441598
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)